82.       Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, McCarthy WH, Murad TM, Maddox WA: Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer 1983;52:1748-1753.

83.       Beral V, Evans S, Shaw H, Milton G: Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983;109:165-172.

84.       Bindon C, Czerniecki M, Ruell P, Edwards A, McCarthy WH, Harris R, Hersey P: Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects. Br J Cancer 1983;47:123-133.

85.       Bolton EM, Thompson JF, Wood RF, Morris PJ: Immunoperoxidase staining of fine-needle aspiration biopsies and needle core biopsies from renal allografts. Transplantation 1983;36:728-731.

86.       Carter NP, Cullen PR, Thompson JF, Bewick ALT, Wood RFM, Morris PJ: Monitoring lymphocyte subpopulations in renal allograft recipients. Transplant Proc 1983;15:1157-1159.

87.       French ME, Thompson JF, Hunnisett AGW, Wood RFM, Morris PJ: Impaired function of renal allografts during treatment with cyclosporin A: nephrotoxicity or rejection? Transplant Proc 1983;15:485-488.

88.       Hersey P, Bindon C, Czerniecki M, Spurling A, Wass J, McCarthy WH: Inhibition of interleukin 2 production by factors released from tumor cells. J Immunol 1983;131:2837-2842.

89.       Hersey P, Bradley M, Hasic E, Haran G, Edwards A, McCarthy WH: Immunological effects of solarium exposure. Lancet 1983;1:545-548.

90.       Hersey P, Edwards A, Milton GW, McCarthy WH: No evidence for an association between natural killer cell activity and prognosis in melanoma patients. Nat Immun Cell Growth Regul 1983;3:87-94.

91.       Hersey P, Edwards A, Murray E, McCarthy WH, Milton GW: Prognostic significance of leukocyte-dependent antibody activity in melanoma patients. J Natl Cancer Inst 1983;71:45-53.

92.       Hersey P, Grace J, Murray E, Palmer A, McCarthy WH: Expression of Thy-1 antigen on human melanoma cells. Int J Cancer 1983;32:21-25.

93.       Kourtesis GJ, McCarthy WH, Milton GW: Major amputations for melanoma. Aust N Z J Surg 1983;53:241-244.

94.       McGovern VJ, Shaw HM, Milton GW: Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 1983;7:673-680.

95.       McGovern VJ, Shaw HM, Milton GW: Prognostic significance of a polypoid configuration in malignant melanoma. Histopathology 1983;7:663-672.

96.       Morris PJ, French ME, Dunnill MS, Hunnisett AG, Ting A, Thompson JF, Wood RF: A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983;36:273-277.

97.       Mortimer PS, Thompson JF, Dawber RP, Ryan TJ, Morris PJ: Hypertrichosis and multiple cutaneous squamous cell carcinomas in association with cyclosporin A therapy. J R Soc Med 1983;76:786-787.

98.       Reddel RR, Thompson JF, Raghavan D, Tattersall MH, Levi JA, Coupland GA, Fox RM, Coates AS, Woods RL, Ng AB: Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy. J Surg Oncol 1983;23:223-227.

99.       Scheibner A, McCarthy WH, Milton GW, Nordlund JJ: Langerhans cell and melanocyte distribution in "normal" human epidermis. Preliminary report. Australas J Dermatol 1983;24:9-16.

100.    Thompson JF, Chalmers DH, Carter NP, Wood RFM, Morris PJ: Clinical and immunologic effects of conversion to cyclosporin A therapy in long-term renal allograft recipients. Transplant Proc 1983;15:1930-1932.

101.    Thompson JF, Chalmers DH, Hunnisett AG, Wood RF, Morris PJ: Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. Transplantation 1983;36:204-206.

102.    Thompson JF, Chalmers DH, Wood RF, Kirkham SR, Morris PJ: Sudden death following high-dose intravenous methylprednisolone. Transplantation 1983;36:594-596.

103.    Thompson JF, Chalmers DHK, Wood RFM, Morris PJ: Renal allograft monitoring by fine needle aspirtaion cytology. Transplantation and Clinical Immunology 1983;15:207-217.

104.    Thompson JF, Walker CJ: The management of pancreatic carcinoma: a review of 173 cases. Aust N Z J Surg 1983;53:25-30.

105.    Thompson JF, Wood RF, Cahill AP, Franklin PM, Morris PJ: Kidney transplantation and seat belt legislation. Br Med J (Clin Res Ed) 1983;287:1260-1261.

106.    Wood RFM, Bolton EM, Thompson JF, Morris PJ, Mason DY: Characterisation of cellular infiltrates in renal allografts by fine-needle aspiration - a simple technique using double labelling with monoclonal antibodies. Transplant Proc 1983;15:1847-1848.

107.    Wood RFM, Thompson JF, Allen NH, Ting A, Morris PJ: The consequences of conversion from cyclosporine to azathioprine and prednisolone in renal allograft recipients. Transplant Proc 1983;15:2862-2868.